Cannabinoids for Medical Purposes in Children: A Living Systematic Review.

ABSTRACT:

Aim

We developed a living systematic review (LSR) that will continuously map the safety and reported benefit data related to cannabinoid use for medical purposes in children.

Methods

MEDLINE, Embase, PsycInfo, and the Cochrane Library were searched from inception to April 2023. Studies involving at least one child < 18 years who was administered plant-derived or pharmaceutical cannabinoids as an intervention or treatment for medical conditions were included.

Results

Of 37 189 identified citations, 276 studies were included: 84 interventional, 131 observational, 54 surveys, and 7 qualitative studies. Among interventional and observational studies, common indications for cannabinoids in children were refractory epilepsy (n = 146 studies, 188 726 participants), cancer an

SUBMITTER: Chhabra M 

PROVIDER: S-EPMC12336964 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature